Anemia, Refractory, With Excess of Blasts
4 clinical trials · Condition
◉ Watch Anemia, Refractory, With Excess of Blasts
| Record | Firm | Date |
|---|---|---|
| IGF-MTX Conjugate in the Treatment of Myelodysplastic Syndrome (NCT03175978) | IGF Oncology, LLC | 2018-02-21 |
| T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies (NCT01163201) | Masonic Cancer Center, University of Minnesota | 2014-01-01 |
| Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies (NCT01461538) | Seagen Inc. | 2011-10-01 |
| Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies (NCT00038051) | M.D. Anderson Cancer Center | 1999-05-01 |
Track Anemia, Refractory, With Excess of Blasts automatically
Every clearance here is in the API, with alerts when new ones post.